Your search returned 64 studies. (Get alerts for new studies):
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Jackson, Tennessee
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Jackson, Tennessee
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Jackson, Tennessee
- Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Nashville, Tennessee
- SCRI TISSUE TESTING REGISTRY
Conditions: Melanoma - Myelodysplastic Syndrome - Multiple Myeloma - Lymphoma
Location: Nashville, Tennessee
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: Jackson, Tennessee
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Jackson, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Jackson, Tennessee
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease - Smoldering Multiple Myeloma
Location: Jackson, Tennessee
- FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
Conditions: Colorectal Cancer
Location: Nashville, Tennessee
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Jackson, Tennessee
- Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthriti
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Prematurity and Respiratory Outcomes Program (PROP)
Conditions: Prematurity - Respiratory Disease
Location: Jackson, Tennessee
- Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
Conditions: Prematurity - Bronchopulmonary Dysplasia - Chronic Lung Disease of Prematurity
Location: Jackson, Tennessee
- A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus
Location: Jackson, Tennessee
- Epidermal Growth Factor Receptor-tested Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer
Conditions: Non Small Cell Lung Cancer
Location: Nashville, Tennessee
- Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis
Conditions: Ankylosing Spondyloarthritis
Location: Jackson, Tennessee
- Phase IIb Study of Dasatinib Versus Imatinib in Patients With CML-CP Who Have Not Achieved an Early Optimal Response to Imatinib
Conditions: Chronic Phase Chronic Myeloid Leukemia
Location: Nashville, Tennessee
- Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal
Conditions: Malignant Solid Tumour - Gastrooesophageal Cancer
Location: Nashville, Tennessee
- Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemoth
Conditions: Diffuse Large B-Cell Lymphoma
Location: Nashville, Tennessee
- Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo
Conditions: Impetigo
Location: Milan, Tennessee
- Secukinumab Efficacy and Safety Study in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-TNFα Agents.
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Conditions: Meningitis - Meningococcal Infection - Diphtheria - Tetanus - Pertussis - Haemophilus Influenzae Serotype b (Hib)
Location: Jackson, Tennessee
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Jackson, Tennessee
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Jackson, Tennessee
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Jackson, Tennessee
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Jackson, Tennessee
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Conditions: Neoplasms, Breast - Breast Cancer
Location: Jackson, Tennessee
- Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma
Location: Nashville, Tennessee
- Trial of Poor Performance Status Patients (ToPPS)
Conditions: Non Small Cell Lung Cancer
Location: Nashville, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Dickson, Tennessee
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
Location: Jackson, Tennessee
- Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Jackson, Tennessee
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Jackson, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Dickson, Tennessee
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Jackson, Tennessee
- Growth of Infants Fed an Extensively Hydrolyzed Infant Formula
Conditions: Growth
Location: Jackson, Tennessee
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Jackson, Tennessee
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Jackson, Tennessee
- Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 1 Year of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Conditions: Coronary Artery Disease - Angina Pectoris
Location: Jackson, Tennessee
- A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
Conditions: Cutaneous Lupus Erythematosus
Location: Jackson, Tennessee
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Jackson, Tennessee
- Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Conditions: Tophaceous Gout
Location: Jackson, Tennessee
- A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: McKenzie, Tennessee
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Jackson, Tennessee
- A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
Conditions: Inflammation - Rheumatoid Arthritis
Location: Jackson, Tennessee
- A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate
Conditions: Inflammation - Rheumatoid Arthritis
Location: Jackson, Tennessee
- Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Conditions: Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.
Location: Jackson, Tennessee
- The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Conditions: Coronary Artery Disease
Location: Jackson, Tennessee
- Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures
Conditions: Chronic Anal Fissures
Location: Jackson, Tennessee
- A Study of Ixekizumab in Participants With Active Psoriatic Arthritis
Conditions: Psoriasis, Arthritic
Location: Jackson, Tennessee
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Cr
Conditions: Inflammation - Crohn's Disease
Location: Jackson, Tennessee
- Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2
Conditions: Hyperlipidemia
Location: Jackson, Tennessee
- LDL-C Assessment w/ PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Conditions: Hyperlipidemia
Location: Jackson, Tennessee
- LDL-C Assessment w/ PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Conditions: Hyperlipidemia
Location: Jackson, Tennessee
- Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Conditions: Dyslipidemia
Location: Jackson, Tennessee
- An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
|